Skip to main content

Exploring New Approaches in AML Treatment

June 22, 2021

Topics Covered

We invite you to learn more about:

  • Emerging therapies for acute myeloid leukemia (AML)
  • Precision medicine for AML 
  • Managing side-effects   
  • The importance of open communication with your treatment team

Program Materials


Joseph G. Jurcic, MD
Professor of Medicine
Columbia University Irving Medical Center
Director, Hematologic Malignancies
Attending Physician, New York-Presbyterian Hospital
Member, Herbert Irving Comprehensive Cancer Center
New York, NY

Program Support

Support for this program is provided by Agios; Bristol Myers Squibb; Genentech, Inc. & Biogen, and Jazz Pharmaceuticals.


< Back to Webcasts